Home › Funds › CPP Investments › BCRX
CPP Investments position in BCRX
BIOCRYST PHARMACEUTICALS INC · Health Care
Latest position (Q2 2026)115.81K sh
Reported value held$1.16M
Portfolio Weight0.00%
First reportedQ4 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2021 | 215 | $3.00K | New |
| Q3 2022 | 8.10K | $102.00K | New |
| Q4 2022 | 184.70K | $2.12M | Add |
| Q1 2023 | 113.80K | $949.09K | Reduce |
| Q2 2023 | 113.80K | $801.15K | Hold |
| Q3 2023 | 113.80K | $805.70K | Hold |
| Q4 2023 | 113.80K | $681.66K | Hold |
| Q1 2024 | 113.80K | $578.10K | Hold |
| Q2 2024 | 113.80K | $703.28K | Hold |
| Q3 2024 | 10.64K | $80.87K | Reduce |
| Q4 2024 | 10.64K | $80.02K | Hold |
| Q1 2025 | 10.64K | $79.81K | Hold |
| Q1 2025 | 10.64K | $79.81K | Hold |
| Q2 2025 | 510.34K | $4.57M | Add |
| Q2 2025 | 510.34K | $4.57M | Add |
| Q3 2025 | 230.34K | $1.75M | Reduce |
| Q4 2025 | 327.94K | $2.56M | Add |
| Q1 2026 | 118.00K | $1.12M | Reduce |
| Q2 2026 | 115.81K | $1.16M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding BCRX
- BlackRock Inc 23.89M sh · $238.93M · Q2 2026
- Vanguard Group 22.27M sh · $173.73M · Q4 2025
- Janus Henderson Group 8.91M sh · $84.85M · Q1 2026
- Two Sigma Investments 6.78M sh · $67.75M · Q2 2026
- Geode Capital Management 6.25M sh · $62.49M · Q2 2026
- UBS Group AG 5.08M sh · $50.78M · Q2 2026
- Bank of America Corp 4.80M sh · $48.01M · Q2 2026
- Goldman Sachs Group 4.48M sh · $44.82M · Q2 2026
- Millennium Management 3.39M sh · $33.95M · Q2 2026
- Renaissance Technologies 2.53M sh · $25.30M · Q2 2026
- Charles Schwab Investment Management 2.35M sh · $23.53M · Q2 2026
- Northern Trust Corp 2.26M sh · $22.56M · Q2 2026